Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 382

MFS Investments: Blue wave fails to reach shore

While the final outcome of the US general election remains undecided, a few things have become clear: Republicans appear poised to retain control of the Senate and look likely to narrow the Democrats’ majority in the House of Representatives. The presidential race hangs in the balance, but even if former Vice President Joe Biden prevails over incumbent Donald Trump, he will likely find himself constrained legislatively.

The outlook suggests that markets anticipate lower levels of stimulus than would have occurred under a 'blue wave' scenario in which the Democrats swept both houses of Congress with comfortable majorities and regained the White House.

Markets expected such an outcome in recent weeks and priced in a 'reflation trade', pushing up long-term interest rates, value stocks, cyclical names and small-cap equities. Much of that trade is being unwound, flattening the yield curve, pushing long-term rates, real yields and inflation expectations lower while boosting stay-at-home equities, large caps, and high-tax- paying companies and undermining renewables, infrastructure and companies taxed at lower rates.

Volatility measures have declined, but the CBOE Volatility Index (VIX) futures curve remains inverted and elevated relative to its history, suggesting higher-than-normal levels of volatility into early 2021.

Should Vice President Biden ultimately win, in my view he would enter office with a weak mandate relative to expectations given his underperformance and the underperformance of his party. However, the executive branch wields a great deal of power when it comes to the nation’s regulatory framework. Therefore it will be interesting to see, if Biden does win, whether his approach to regulation will also be constrained. US presidents additionally exercise tremendous power on the trade front. In this area a President Biden would be less confrontational than President Trump.

Here are our takeaways assuming a Biden victory:

  1. A multitrillion-dollar stimulus package that includes elements of the Green New Deal is likely off the table.
  2. A public option for health care insurance is also unlikely given the projected makeup of the next US Senate.
  3. The Senate will almost certainly block Biden’s plan to raise taxes on corporations and high- earning individuals.
  4. One area of potential bipartisan agreement on fiscal policy could be a moderately sized infrastructure package, given the combination of relatively high unemployment as a result of the pandemic, along with near-record-low borrowing rates.

Regardless of the election’s outcome, the economy remains impaired by the pandemic and the outlook has been complicated by the fact that the trajectory of profit margins peaked and was heading lower long before the pandemic triggered the recession. Further, a vaccine won’t cure a decade of increasingly leveraged corporate balance sheets.

Against this uncertain backdrop, we continue to seek to own companies we think will survive and emerge stronger when the pandemic subsides — with or without stimulus — while avoiding those we believe are structurally disadvantaged.

 

Robert M. Almeida is a Global Investment Strategist and Portfolio Manager at MFS Investment Management. This article is for general informational purposes only and should not be considered investment advice or a recommendation to invest in any security or to adopt any investment strategy. Comments, opinions and analysis are rendered as of the date given and may change without notice due to market conditions and other factors. This article is issued in Australia by MFS International Australia Pty Ltd (ABN 68 607 579 537, AFSL 485343), a sponsor of Firstlinks.

For more articles and papers from MFS, please click here.

Unless otherwise indicated, logos and product and service names are trademarks of MFS® and its affiliates and may be registered in certain countries.

 

RELATED ARTICLES

The 2020 US presidential elections

Capital Group: What the U.S. election means for investors

Why mega-tech growth are the best ‘value’ stocks in the market

banner

Most viewed in recent weeks

10 little-known pension traps prove the value of advice

Most people entering retirement do not see a financial adviser, mainly due to cost. It's a major problem because there are small mistakes a retiree can make which are expensive and avoidable if a few tips were known.

Check eligibility for the Commonwealth Seniors Health Card

Eligibility for the Commonwealth Seniors Health Card has no asset test and a relatively high income test. It's worth checking eligibility and the benefits of qualifying to save on the cost of medications.

Hamish Douglass on why the movie hasn’t ended yet

The focus is on Magellan for its investment performance and departure of the CEO, but Douglass says the pandemic, inflation, rising rates and Middle East tensions have not played out. Vindication is always long term.

Start the year right with the 2022 Retiree Checklist

This is our annual checklist of what retirees need to be aware of in 2022. It is a long list of 25 items and not everything will apply to your situation. Run your eye over the benefits and entitlements.

At 98-years-old, Charlie Munger still delivers the one-liners

The Warren Buffett/Charlie Munger partnership is the stuff of legends, but even Charlie admits it is coming to an end ("I'm nearly dead"). He is one of the few people in investing prepared to say what he thinks.

Should I pay off the mortgage or top up my superannuation?

Depending on personal circumstances, it may be time to rethink the bias to paying down housing debt over wealth accumulation in super. Do the sums and ask these four questions to plan for your future.

Latest Updates

Investment strategies

Three ways index investing masks extra risk

There are thousands of different indexes, and they are not all diversified and broadly-based. Watch for concentration risk in sectors and companies, and know the underlying assets in case liquidity is needed.

Investment strategies

Will 2022 be the year for quality companies?

It is easy to feel like an investing genius over the last 10 years, with most asset classes making wonderful gains. But if there's a setback, companies like Reece, ARB, Cochlear, REA Group and CSL will recover best.

Shares

2022 outlook: buy a raincoat but don't put it on yet

In the 11th year of a bull market, near the end of the cycle, some type of correction is likely. Underneath is solid, healthy and underpinned by strong earnings growth, but there's less room for mistakes.

Gold

Time to give up on gold?

In 2021, the gold price failed to sustain its strong rise since 2018, although it recovered after early losses. But where does gold sit in a world of inflation, rising rates and a competitor like Bitcoin?

Investment strategies

Global leaders reveal surprises of 2021, challenges for 2022

In a sentence or two, global experts across many fields are asked to summarise the biggest surprise of 2021, and enduring challenges into 2022. It's a short and sweet view of the changes we are all facing.

Shares

2021 was a standout year for stockmarket listings

In 2021, sharemarket gains supported record levels of capital raisings and IPOs in Australia. The range of deals listed here shows the maturity of the local market in providing equity capital.

Economy

Let 'er rip: how high can debt-to-GDP ratios soar?

Governments and investors have been complacent about the build up of debt, but at some level, a ceiling exists. Are we near yet? Trouble is brewing, especially in the eurozone and emerging countries.

Sponsors

Alliances

© 2022 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.